Masahiro Ishikane

2.4k total citations
120 papers, 1.1k citations indexed

About

Masahiro Ishikane is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Masahiro Ishikane has authored 120 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 46 papers in Epidemiology and 28 papers in Applied Microbiology and Biotechnology. Recurrent topics in Masahiro Ishikane's work include Antibiotic Use and Resistance (28 papers), COVID-19 Clinical Research Studies (22 papers) and SARS-CoV-2 and COVID-19 Research (15 papers). Masahiro Ishikane is often cited by papers focused on Antibiotic Use and Resistance (28 papers), COVID-19 Clinical Research Studies (22 papers) and SARS-CoV-2 and COVID-19 Research (15 papers). Masahiro Ishikane collaborates with scholars based in Japan, United States and Sweden. Masahiro Ishikane's co-authors include Peter Ueda, Haruka Sakamoto, Norio Ohmagari, Yoshiki Kusama, Cyrus Ghaznavi, Kayoko Hayakawa, Yuichi Muraki, Satoshi Kutsuna, Tamano Matsui and Tomimasa Sunagawa and has published in prestigious journals such as JAMA, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Masahiro Ishikane

107 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiro Ishikane Japan 16 420 386 216 126 110 120 1.1k
Se Yoon Park South Korea 17 330 0.8× 586 1.5× 150 0.7× 90 0.7× 101 0.9× 102 1.2k
Shinya Tsuzuki Japan 21 425 1.0× 512 1.3× 150 0.7× 127 1.0× 86 0.8× 104 1.3k
Workeabeba Abebe Ethiopia 15 231 0.6× 235 0.6× 157 0.7× 112 0.9× 69 0.6× 62 866
Nimalie D. Stone United States 24 509 1.2× 531 1.4× 242 1.1× 128 1.0× 123 1.1× 70 1.5k
Charlotte Jackson United Kingdom 20 681 1.6× 467 1.2× 176 0.8× 123 1.0× 88 0.8× 43 1.3k
Davide Fiore Bavaro Italy 18 243 0.6× 421 1.1× 180 0.8× 66 0.5× 73 0.7× 74 1.1k
Jessica P. Ridgway United States 22 664 1.6× 926 2.4× 154 0.7× 80 0.6× 134 1.2× 94 1.5k
Tark Kim South Korea 19 488 1.2× 693 1.8× 66 0.3× 67 0.5× 124 1.1× 72 1.2k
Michelle Science Canada 21 896 2.1× 771 2.0× 123 0.6× 86 0.7× 239 2.2× 86 1.9k
Tommaso Lupia Italy 16 237 0.6× 348 0.9× 99 0.5× 57 0.5× 61 0.6× 80 954

Countries citing papers authored by Masahiro Ishikane

Since Specialization
Citations

This map shows the geographic impact of Masahiro Ishikane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Ishikane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Ishikane more than expected).

Fields of papers citing papers by Masahiro Ishikane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Ishikane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Ishikane. The network helps show where Masahiro Ishikane may publish in the future.

Co-authorship network of co-authors of Masahiro Ishikane

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Ishikane. A scholar is included among the top collaborators of Masahiro Ishikane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Ishikane. Masahiro Ishikane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Itoh, Naoya, Masahiro Ishikane, Noriko Iwamoto, et al.. (2025). Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients. Journal of Infection and Chemotherapy. 31(4). 102631–102631. 2 indexed citations
2.
Miura, Fuminari, Masahiro Ishikane, Noriko Iwamoto, et al.. (2025). Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo. Science Translational Medicine. 17(805). eads4773–eads4773.
3.
Hart, William S., Robin N. Thompson, Masahiro Ishikane, et al.. (2024). Modelling the effectiveness of an isolation strategy for managing mpox outbreaks with variable infectiousness profiles. Nature Communications. 15(1). 7112–7112. 4 indexed citations
4.
Tsugawa, Yusuke, et al.. (2024). Clinic Characteristics and Antibiotic Prescribing for Acute Respiratory Infections in Japan. JAMA Network Open. 7(10). e2440406–e2440406. 1 indexed citations
5.
Ghaznavi, Cyrus, Peter Ueda, Shuhei Nomura, et al.. (2024). Factors associated with lifetime use of commercial sex work services among Japanese men aged 20–49: findings from a quasi-representative national survey, 2022. Sexually Transmitted Infections. 100(6). 371–380. 1 indexed citations
6.
7.
Kusama, Yoshiki, Yusuke Asai, Shinya Tsuzuki, et al.. (2023). Effects of population age structure on parenteral antimicrobial use estimations. Scientific Reports. 13(1). 840–840. 1 indexed citations
8.
Itoh, Naoya, Hanako Kurai, Ichiro Kawamura, et al.. (2023). A nationwide cross-sectional study using a web-based questionnaire survey of the duration of isolation of COVID-19 inpatients with cancer at Japanese cancer centers. Journal of Infection and Chemotherapy. 29(12). 1185–1188. 1 indexed citations
9.
Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2022). Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection. International Journal of Infectious Diseases. 119. 18–20.
10.
Itoh, Naoya, et al.. (2022). Lessons learned from an outbreak of COVID-19 in the head and neck surgery ward of a Japanese cancer center during the sixth wave by Omicron. Journal of Infection and Chemotherapy. 28(12). 1610–1615. 7 indexed citations
11.
12.
Ghaznavi, Cyrus, Masahiro Ishikane, Daisuke Yoneoka, et al.. (2022). Effect of the COVID-19 pandemic and state of emergency declarations on the relative incidence of legionellosis and invasive pneumococcal disease in Japan. Journal of Infection and Chemotherapy. 29(1). 90–94. 1 indexed citations
13.
Pham, Thao Thi Ngoc, Masahiro Ishikane, Satoshi Kutsuna, et al.. (2022). Physical oral care prevents ventilator-associated pneumonia in Vietnam: A prospective interventional study. Journal of Infection and Chemotherapy. 28(12). 1632–1638. 4 indexed citations
14.
Ishikane, Masahiro, et al.. (2021). A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient. International Journal of Infectious Diseases. 113. 55–57. 15 indexed citations
15.
Miyazato, Yusuke, et al.. (2021). Acute portal vein thrombosis with COVID-19 and cirrhosis. IDCases. 24. e01094–e01094. 1 indexed citations
16.
Nomoto, Hidetoshi, Masahiro Ishikane, Takato Nakamoto, et al.. (2020). Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019. PLoS ONE. 15(4). e0231966–e0231966. 8 indexed citations
17.
Kusama, Yoshiki, Masahiro Ishikane, Chika Tanaka, et al.. (2020). Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings. JAC-Antimicrobial Resistance. 2(1). dlaa004–dlaa004. 3 indexed citations
18.
Moriyama, Yuki, Masahiro Ishikane, Yoshiki Kusama, et al.. (2019). 2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan. Open Forum Infectious Diseases. 6(Supplement_2). S682–S683.
19.
Ishikane, Masahiro, Kayoko Hayakawa, Satoshi Kutsuna, Nozomi Takeshita, & Norio Ohmagari. (2019). The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years. PLoS ONE. 14(4). e0215996–e0215996. 24 indexed citations
20.
Ishikane, Masahiro & Junko Tanuma. (2014). Mycobacterium avium complex enteritis in HIV-infected patient. IDCases. 1(2). 22–23. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Se Yoon Park Breakdown of academic impact, for papers by Shinya Tsuzuki Breakdown of academic impact, for papers by Workeabeba Abebe Breakdown of academic impact, for papers by Nimalie D. Stone Breakdown of academic impact, for papers by Charlotte Jackson Breakdown of academic impact, for papers by Davide Fiore Bavaro Breakdown of academic impact, for papers by Jessica P. Ridgway Breakdown of academic impact, for papers by Tark Kim Breakdown of academic impact, for papers by Michelle Science Breakdown of academic impact, for papers by Tommaso Lupia
Rankless by CCL
2026